Clinical Trial

Genomic Determinants of Outcome in Cardiogenic Shock

Study acronym: Goldilocs
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this project is to understand the heterogeneity of both the immune consequences and treatment responses in CS. We will explore this heterogeneity through identification of transcriptomic sub-phenotypes and their association with outcomes, including therapeutic responses.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-13; most recent amendment 2025-11-17.
Trial Details
NCT Number NCT05728359
Lead Sponsor Barts & The London NHS Trust
Collaborators: University of Oxford
Conditions Cardiogenic Shock
Enrollment 300 participants
Start Date 2022-08-08
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-18